Novel compound heterozygous mutations of ALDH1A3 contribute to anophthalmia in a non-consanguineous Chinese family

Abstract

Anophthalmia is a rare eye development anomaly resulting in absent ocular globes or tissue in the orbit since birth. Here, we investigated a newborn with bilateral anophthalmia in a Chinese family. Exome sequencing revealed that compound heterozygous mutations c.287G > A (p.(Arg96His)) and c.709G > A (p.(Gly237Arg)) of the ALDH1A3 gene were present in the affected newborn. Both mutations were absent in all of the searched databases, including 10,000 in-house Chinese exome sequences, and these mutations were confirmed as having been transmitted from the parents. Comparative amino acid sequence analysis across distantly related species revealed that the residues at positions 96 and 234 were evolutionarily highly conserved. In silico analysis predicted these changes to be damaging, and in vitro expression analysis revealed that the mutated alleles were associated with decreased protein production and impaired tetrameric protein formation. This study firstly reported that compound heterozygous mutations of the ALDH1A3 gene can result in anophthalmia in humans, thus highlighting those heterozygous mutations in ALDH1A3 should be considered for molecular screening in anophthalmia, particularly in cases from families without consanguineous relationships.

Keywords:
Anophthalmia; exome sequence; ALDH1A3; compound heterozygous mutations

Introduction

Anophthalmia and microphthalmia (A/M, OMIM 206900) are rare inborn defects of eye development and show a phenotypic continuum from the complete absence of the eye globes (A) to the small eyes (M), as defined in terms of axial length and corneal diameter. A/M can be isolated or associated with other anomalies. Anophthalmia rarely occurs in isolation, with its birth prevalence ranging from 0.6 to 4.2 per 100,000 births (Skalicky et al., 2013).

Genetic mutations are proposed as a predominant etiology for these ocular global anomalies (Bermejo and Martinez-Frias, 1998). The genetic foundations of A/M were demonstrated with a high degree of heterogeneity, including chromosomal abnormalities and monogenic mutations. Mutations in over 20 genes have been reported to contribute to A/M with dominant, recessive, or X-linked inheritance patterns (Chassaing, 2014). Among these, the SOX2 (OMIM 184429) and OTX2 (OMIM 600037) gene mutations are the major cause of A/M, each accounting for approximately 10–20% and 4–8% of dominant cases, respectively (Schneider et al., 2009; Schilter et al., 2011), and the FOXE3 (OMIM 601094) gene mutation is a common source of recessive microphthalmia and explains approximately 15% of the dominant cases (Reis et al., 2010). Recently, the ALDH1A3 gene (OMIM 600463) mutations were revealed to underlie autosomal recessive A/M and was estimated to be responsible for approximately 10% of the cases in consanguineous families (Fares-Taie et al., 2013; Abouzeid et al., 2014). Despite this progresses in understanding the genetic basis of A/M, more than 50% of A/M patients still have unknown causes.

Next-generation sequencing with exome selection has been successfully employed to identify the causative genes mutations in genetically heterogeneous disorders. Whole-exome sequencing (WES) has been shown to be effective in both screening known genes and searching for new causative factors in families with A/M (Aldahmesh et al., 2012; Fares-Taie et al., 2013; Yahyavi et al., 2013; Slavotinek et al., 2015). Herein, we investigated a newborn boy with bilateral anophthalmia in a non-consanguineous Chinese family using WES and further confirmed the causative gene by bioinformatics and in vitro expression analyses.

Subjects and Methods

Subjects

The family included in this study is of Han Chinese origin and resides in Chengdu City of Sichuan Province. The proband was a 25-day-old newborn boy with anophthalmia. His examination showed an absence of eyes, short eyelids and reduced palpebral fissures (Figure 1A). Ocular ultrasonography revealed that the posterior segments of both eyes were malformed and reduced in size, the ocular walls were irregular in shape and the left-sided optic disk region was abnormally depressed; some vitreous cysts were detected in the right orbit (Figure 1B, C). Cerebral magnetic resonance imaging (MRI) at 1 week of age displayed seriously deformed eye globes without well-defined borders, and the lenses were missing on both sides (Figure 1D). The boy was born by vertex vaginal delivery at full term. He passed the newborn hearing screen. Both young parents were phenotypically normal and reported no history of ocular abnormalities in their family members; however, the parents reported that their first fetus was terminated due to similar eye defects after ultrasonic inspection during pregnancy. The pedigree is shown in Figure 2A.

Figure 1
Clinical and imaging features of the affected boy. A. Eyes of the boy affected with anophthalmia. B and C. Ultrasonography shows an anophthalmic socket on the left orbit and some vitreous cysts present in the right orbit, indicated circles. D. MRI shows an anophthalmic socket and remnant fibrotic tissue in the intraorbital region and hypoplastic optic nerve bilaterally, indicated by arrows (Axial T2-weighted MR image with fat-suppression).

Figure 2
Family pedigree of the anophthalmia case and the mutation transmission of the ALDH1A3 gene. A. Family pedigree of the case. B. Sequence analysis shows that the father (I1) was heterozygous at c.287G > A in ALDH1A3 exon 3, the mother (I2) was heterozygous at c.709G > A in ALDH1A3 exon 7, and the affected boy (II1) was heterozygous at both sites. C. Comparison of the amino-acid sequences near the R96 and G237 of ALDHs from different organisms (NCBI accession numbers: H. sapiens ADLH1A3: NP_000684, ADLH1A1: NP_000680, ADLH1A2: NP_733798, D. rerio: NP_001038210, M. musculus: NP_444310.3, G. gallus: NP_990000.1, and A. carolinesis: ENSACAT00000009770). The red arrows indicate the sites of mutated amino acids.

The current study was reviewed and approved by the Research Ethics Committee of the West China Hospital, West China Medical School, Sichuan University. Informed written consent was obtained from both parents, and consent was obtained on behalf of their son.

Whole-exome sequencing (WES)

Blood was collected from all family members and genomic DNA was extracted according to standard procedures. The genomic DNA of the affected boy was randomly fragmented into an average size of 100~300 bp and ligated with a pair of linkers at both ends. The fragmented DNA was amplified by ligation-mediated polymerase chain reaction (LM-PCR) and hybrid-ized to a NimbleGen probe capture array (SeqCap EZ Exome Kit v3.0, covering more than 20,000 genes in the human genome, Roche NimbleGen, Madison, WI, USA). The captured LM-PCR products were subjected to quantitative PCR to estimate the magnitude of enrichment and were then loaded onto the Illumina Hiseq2500 platform (Illumina, San Diego, CA) for next-generation sequencing. Two parallel reactions were conducted.

Genetic variations analysis

The sequencing read depth was 160.94 x on average, and the mean coverage was 99.76%. Low-quality variations were filtered out using a quality score ≥ 20 (Q20). Sequencing reads were aligned to the NCBI human reference genome (hg19) using Burrows-Wheeler Aligner. Single nucleotide polymorphisms (SNPs) and insertion/deletion (indel) of the sequence were analyzed using SAMtools and Pindel. All genetic variations were screened in the dbSNP147, Exome Variant Server, 1000 Genomes and in-house 10,000 Chinese exome database (Joy Orient, Beijing, China) to exclude common variants. Each rare missense mutation (MAF < 0.01) was tested for potential pathogenicity using SIFT (http://sift.jcvi.org/) and Polyphen-2 (http://genetics.bwh.harvard.edu/pph2/). The candidate gene variations were also searched in the Online Mendelian Inheritance in Man database (OMIM, http://www.omim.org/) and the human gene mutation database (HGMD, http://www.hgmd.cf.ac.uk/). Sanger sequencing was used to verify the variations of candidate genes in the affected baby and his parents.

In vitro expression analysis of the ALDH1A3 mutations

To examine the effects of ALDH1A3 mutations, two sets of expression vectors were constructed based on the commercial plasmids pReceiver-M45 and -M46 (Genecopoeia, Rockville, MD), each set was tagged with HA and FLAG, respectively. All constructs were verified by sequencing.

The constructed plasmids were transfected into the 293T cells using a jetPRIME transfection kit (Polyplus, Illkirch, France). After 48 hours, the whole RNAs of each well were extracted, and the mRNA levels of wild type and mutant ALDH1A3 transcripts were examined by quantitative reverse transcription PCR (qRT-PCR) analysis. In addition, the whole protein lysates from each well were extracted and analyzed using immunoblotting (IB) with the anti-HA (Abcam, Cambridge, MA) and anti-FLAG (Sigma-Aldrich, St. Louis, MO) antibodies, respectively. Briefly, an IB analysis involved the following steps: the protein lysates were separated on 10% SDS-polyacrylamide gels and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Temecula, CA). The transferred membranes were blocked with 10% dry milk and sequentially incubated with primary antibodies and horseradish peroxidase (HRP)-conjugated second antibodies. The immunoreactive bands were identified using a chemiluminescent HRP substrate kit (Millipore). Green fluorescent protein (GFP) was used as an internal control.

To further examine the interaction of the mutated monomers of the ALDH1A3 proteins, co-immunoprecipitation (Co-IP) analyses were performed according to the manufacturer's instructions. Briefly, the extracted proteins were incubated with 3 μg of HA antibody (Santa Cruz, Dallas, TX) per sample. Then, protein A+G agarose beads (Beyotime, Shanghai, China) were added to each incubation sample. The bound proteins were isolated by centrifugation and purified with PBS. Finally, the Co-IP proteins were further detected by IB analysis with anti-FLAG antibodies.

Results

Exome sequencing detected 36,195 variants presented in the affected boy (Tables S1 and S2). Among these variants, 489 non-synonymous and frame-shifted variants were predicted to be damaging and potentially pathogenic (Table S3). In this study, the mutations located in the MFRP and ALDH1A3 genes were examined primarily because both candidate genes had been reported to cause A/M in a monogenetic manner.

First, novel biallelic heterozygous mutations at the sites c.287G > A (Genome position: chr15:101427859) in exon 3 and c.709G > A (Genome position: chr15:101436180) in exon 7 of the ALDH1A3 gene were detected in the affected boy (Figure 2B), resulting in two missense mutations of p.(Arg96His) and p.(Gly237Arg). Further sequencing verified that his father is heterozygous in c.287G > A and his mother is heterozygous in c.709G > A of the ALDH1A3 gene (Figure 2B). These two mutations in the ALDH1A3 genes have not previously been reported, and both mutations were absent in all of the searched databases, including the 10,000 Chinese exome database.

The following alignments of the related amino acid sequences in a variety of species using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) revealed that the two amino acid residues Arg96 and Gly237 were highly conserved not only in ALDH1A3 orthologs but also in the two paralogs of ALDH1A1 and ALDH1A2 (Figure 2C). Both ALDH1A3 missense mutations were predicted to be damaging using SIFT (score: 0.00 and 0.00, respectively) and Polyphen-2 (score: 1.00 and 0.99, respectively). Three-dimensional structure modeling of the tetrameric human ALDH1A3 protein was performed using SWISS-MODEL (http://swissmodel.expasy.org/) software with sheep liver cytosolic aldehyde dehydrogenase (PDB entry 1BXS, with 71.26% sequence identity to human ALDH1A3) as a template. The structure illustrated that the arginine (R) at position 96 resided next to the alpha-alpha helix corner, near the subunit contact sites of the ALDH1A3 homo-tetramer (Figure S1A) The glycine (G) at position 237 coiled the beta sheet and alpha helix near the end of the N-terminal domain (Figure S1B). Compared with the protein template PDB 1BXS, the corresponding residue R96 was located inside the nicotinamide adenine dinucelotide (NAD) binding pocket, and G237 was located at the ligand NAD contacting sites (Figure S1B, C). Thus, we deduced that the replacement of the R96 by a histidine (H) may alter the complementary interface among the monomers and then change the conformation of the tetramer, and that the substitution of G237 for the sterically hindered arginine could disrupt NAD binding.

To further examine the potential deleterious effects of the two mutant ALDH1A3 proteins of R96H and G237R, the recombinant wild-type (WT) and two mutant R96H and G237R proteins (Figure 3A) were transiently expressed in the 293T cells. The qRT-PCR analysis showed no significant difference in the mRNA expression levels among WT ALDH1A3, R96H and G237R (Figure S2), whereas the IB analysis of the extracted proteins demonstrated that both R96H and G237R proteins were much less expressed than the WT ALDH1A3 proteins (Figure 3B). Additionally, the subsequent Co-IP analysis showed that the two mutant proteins exhibited diminished binding to each other (Figure 3C). These results indicated that the missense mutations indeed damage the interaction of mutant ALDH1A3 monomers.

Figure 3
In vitro expression of the wild–type ALDH1A3 and two mutant R96H and G237R proteins. A. Scheme for constructing expression vectors for the wild–type ALDH1A3 and two mutant R96H and G237R proteins. B. Expression levels of the wild–type and two mutant ALDH1A3 proteins were examined by the immunoblot analysis with anti-HA and anti-FLAG antibodies. GFP was used as an internal control. The numbers from 1 to 6 indicate the six groups of protein products expressed in 293T cells transfected with different plasmid constructs. B. Interaction of the wild–type and two mutant ALDH1A3 proteins was analyzed by Co-IP analysis with the anti-HA antibody and IB analysis with an anti-FLAG antibody. The numbers from 1 to 6 indicate the different protein products obtained from A. A long exposure shows that the proteins R96H-FLAG and G237R-FlAG can be slightly immunoprecipitated by R96H-HA and G237R-HA.

The boy also harbored a homozygous minor variation of g.119346557 C>T (rs79836575) located at the 5'untranslated region (UTR) of the first exon in the MFRP gene. Although the rs79836575 minor allele (T) frequency is rare in Western populations (< 0.01), this mutation is observed with a much higher frequency of 0.033 in Southern Han Chinese (http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?q=rs79836575). We validated the sequences in both parents and found that the father also had a homozygote TT and the mother a heterozygote CT at this site. Therefore, we excluded the correlation between this UTR variation and anophthalmia in this family.

Discussion

In this study, we showed compound heterozygous mutations of c.287G > A and c.709G > A in the ALDH1A3 gene in a newborn boy with anophthalmia, and the expression of two mutant proteins was significantly decreased in vitro. ALDH1A3 is a critical dehydrogenase that contributes to the conversion of retinaldehyde to retinoic acid, which is vital in the normal morphogenesis of eye development. The ALDH1A3 deficiencies were identified as a direct link between retinoic acid synthesis dysfunction and early eye development malformations in humans (Duester, 2009; Fuhrmann, 2010). The functional analysis in this study indicated that the compound heterozygous ALDH1A3 genetic variants may result in the deficiency of ALDH1A3 function during eye development. These results provided a different insight into the pathogenic roles of new variants.

In addition, we observed that the reduced productions of the two mutant proteins were not caused by a decline in ALDH1A3 mRNAs because none of the transient transcripts showed any differences in their mRNA levels. We proposed that the two mutant R96H and G237R proteins might be unstable and might thus be subjected to proteasomal degradation after synthesis in the cells. This hypothesis was supported by results of the in silico analysis and Co-IP. However, human tissues and samples were unfortunately unavailable to investigate the mutant ALDH1A3 gene expression in vivo because ALDH1A3 expression is primarily present in the salivary gland and prostate, according to the GTEx database (http://www.gtexportal.org). In fact, to examine the effects of the loss-function of the orthologous Aldh1a3 in animals, Yahyavi et al. (2013) constructed a zebrafish model with an Aldh1a3 deficiency using antisense morpholinos targeting the intron 2 and exon 2 boundary of the Aldh1a3 gene. These authors observed that the mutant embryos showed a significant reduction in eye size, delayed closure of the optic fissure and coloboma-like lesions. Hence, to further investigate the function of both mutations, animal models of mouse or zebrafish expressing the mutant R96H and G237R proteins will be helpful in future studies.

The results of the present study revealed that the transmission of compound heterozygous mutations in ALDH1A3 from non-consanguineous parents can lead to A/M, but all previous studies have suggested that homozygous mutations in ALDH1A3 confer autosomal recessive A/M in consanguineous families (Fares-Taie et al., 2013; Aldahmesh et al., 2013; Yahyavi et al., 2013; Abouzeid et al., 2014; Mory et al., 2014; Roos et al., 2014; Semerci et al., 2014; Plaisancié, et al., 2016). Compound heterozygous mutations are common causes of autosomal recessive inherited eye diseases. For example, biallelic heterozygous mutations of DRAM2 and TTLL5 lead to retinal dystrophies (El-Asrag et al., 2015; Sergouniotis et al., 2014), compound heterozygous mutations of ATF6 are the basis of the cone dysfunction disorder achromatopsia (Kohl et al., 2015), and compound heterozygous mutations in OTX2 and MAB21L2 were reported to be a cause of A/M (Ragge et al., 2005; Rainger et al., 2014). Here, these data suggest that the heterozygous mutations of ALDH1A3 contribute to A/M.

In conclusion, we revealed novel compound heterozygous mutations (c.287G>A and c.709G>A) in the ALDH1A3 gene in a newborn with anophthalmia in a non-consanguineous Chinese family. The functional analysis confirmed that these mutations could result in impaired protein production. Thus, we propose that compound heterozygous variants of ALDH1A3 should be considered for genetic screening in A/M cases, particularly in patients from common non-consanguineous families.

Acknowledgments

We would like to thank the study participants, without them, this work would not have been possible. We also acknowledge financial support from the National Natural Science Foundation of China (research grant 81471430).

References

• Abouzeid H, Favez T, Schmid A, Agosti C, Youssef M, Marzouk I, El Shakankiry N, Bayoumi N, Munier FL and Schorderet DF (2014) Mutations in ALDH1A3 represent a frequent cause of microphthalmia/anophthalmia in consanguineous families. Hum Mutat 35:949-953.
• Aldahmesh MA, Mohammed JY, Al-Hazzaa S and Alkuraya FS (2012) Homozyous null mutation in ODZ3 causes microphthalmia in humans. Genet Med 14:900-904.
• Aldahmesh MA, Khan AO, Hijazi H and Alkuraya FS (2013) Mutations in ALDH1A3 cause microphthalmia. Clin Genet 84:128-131.
• Bermejo E and Martinez-Frias ML (1998) Congenital eye malformations: clinical epidemiological analysis of 1,124,654 consecutive births in Spain. Am J Med Genet 75:497-504.
• Chassaing N (2014) Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. Clin Genet 86:326-334.
• Duester G (2009) Keeping an eye on retinoic acid signaling during eye development. Chem Biol Interact 178:178-181.
• El-Asrag ME, Sergouniotis PI, McKibbin M, Plagnol V, Sheridan E, Waseem N, Abdelhamed Z, McKeefry D, Van Schil K, Poulter JA, et al. (2015) Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement. Am J Hum Genet 96:948-954.
• Fares-Taie L, Gerber S, Chassaing N, Clayton-Smith J, Hanein S, Silva E, Serey M, Serre V, Gérard X, Baumann C, et al. (2013) ALDH1A3 mutations cause recessive anophthalmia and microphthalmia. Am J Hum Genet 92:265-270.
• Fuhrmann S (2010) Eye morphogenesis and patterning of the optic vesicle. Curr Top Dev Biol 93:61-84.
• Kohl S, Zobor D, Chiang WC, Weisschuh N, Staller J, Gonzalez Menendez I, Chang S, Beck SC, Garcia Garrido M, Sothilingam V, et al. (2015) Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia. Nat Genet 47:757-765.
• Mory A, Ruiz FX, Dagan E, Yakovtseva EA, Kurolap A, Parés X, Farrés J and Gershoni-Baruch R (2014) A missense mutation in ALDH1A3 causes isolated microphthalmia/anophthalmia in nine individuals from an inbred Muslim kindred. Eur J Hum Genet 22:419-422.
• Plaisancié J, Brémond-Gignac D, Demeer B, Gaston V, Verloes A, Fares-Taie L, Gerber S, Rozet JM, Calvas P and Chassaing N (2016) Incomplete penetrance of biallelic ALDH1A3 mutations. Eur J Med Genet 59:215-218.
• Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, Clarke MP, Russell-Eggitt I, Fielder A, Gerrelli D, Martinez-Barbera JP, et al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 76:1008-1022.
• Rainger J, Pehlivan D, Johansson S, Johansson S, Bengani H, Sanchez-Pulido L, Williamson KA, Ture M, Barker H, Rosendahl K, et al. (2014) Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations. Am J Hum Genet 94:915-923.
• Reis LM, Tyler RC, Schneider A, Bardakjian T, Soucy JF, Melancon SB and Semina EV (2010) FOXE3 plays a significant role in autosomal recessive microphthalmia. Am J Med Genet A 152A:582-590.
• Roos L, Fang M, Dali C, Jensen H, Christoffersen N, Wu B, Zhang J, Xu R, Harris P, Xu X, et al. (2014) A homozygous mutation in a consanguineous family consolidates the role of ALDH1A3 in autosomal recessive microphthalmia. Clin Genet 86:276-281.
• Schilter KF, Schneider A, Bardakjian T, Soucy JF, Tyler RC, Reis LM and Semina EV (2011) OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet 79:158-168.
• Schneider A, Bardakjian T, Reis LM, Tyler RC and Semina EV (2009) Novel SOX2 mutations and genotype-phenotype correlation in anophthalmia and microphthalmia. Am J Med Genet A 149A:2706-2715.
• Semerci CN, Kalay E, Yildirim C, Dinçer T, Olmez A, Toraman B, Koçyigit A, Bulgu Y, Okur V, Satiroglu-Tufan L, et al. (2014) Novel splice-site and missense mutations in the ALDH1A3 gene underlying autosomal recessive anophthalmia /microphthalmia. Br J Ophthalmol 98:832-840.
• Sergouniotis PI, Chakarova C, Murphy C, Becker M, Lenassi E, Arno G, Lek M, MacArthur DG, UCL-Exomes Consortium, Bhattacharya SS, et al. (2014) Biallelic variants in TTLL5, encoding a tubulin glutamylase, cause retinal dystrophy. Am J Hum Genet 94:760-769.
• Skalicky SE, White AJ, Grigg JR, Martin F, Smith J, Jones M, Donaldson C, Smith JE, Flaherty M and Jamieson RV (2013) Microphthalmia, anophthalmia, and coloboma and associated ocular and systemic features: understanding the spectrum. JAMA Ophthalmol 131:1517-1524.
• Slavotinek AM, Garcia ST, Chandratillake G, Bardakjian T, Ullah E, Wu D, Umeda K, Lao R, Tang PL, Wan E, et al. (2015) Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defects. Clin Genet 88:468-473.
• Yahyavi M, Abouzeid H, Gawdat G, de Preux AS, Xiao T, Bardakjian T, Schneider A, Choi A, Jorgenson E, Baier H, et al. (2013) ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and hypoplasia of the optic nerve and optic chiasm. Hum Mol Genet 22:3250-3258.

Supplementary material

The following online material is available for this article:

Table S1 - Single nucleotide polymorphisms (SNPs) identified in the proband.

Table S2 - Insertion/Deletion (INDEL) mutations identified in the proband.

Table S3 - List of 489 non-synonymous and frame-shifting variants.

Figure S1 - Modeling of the three-dimensional structure of ALDH1A3 protein.

Figure S2 - Relative WT ALDH1A3 and mutant R96H and G237R expression levels in 293T cell.

• Associate Editor: Maria Rita Passos-Bueno

Publication Dates

• Publication in this collection
  05 June 2017
• Date of issue
  Apr-Jun 2017

History

• Received
  10 May 2016
• Accepted
  31 Dec 2016